| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.4 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |